You may experience a slight disruption in services
ESMO Breast 2020: will you be among the contributors to the latest data in breast cancer? Submit your abstract by 4 February 2020
The latest standards in the field. Register by 20 November 2019 to discover them
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Olivier Michielin comments on two studies presented at ESMO 2019 providing new insights into the use of liquid biopsy in early detection.
15 Oct 2019
ESMO would like to thank the National Oncology Institute with its office at the National Cancer Institute in Bratislava for providing translation in...
14 Oct 2019
ESMO would like to thank the organisation BISER for providing translation into Serbian
10 Oct 2019
Awarded discoveries paved the way for promising new strategies to fight anaemia, cancer and many other diseases
09 Oct 2019
Systemic exposure to oestradiol could be associated with endometrial hyperplasia/carcinoma, breast and ovarian cancer and thromboembolic events
09 Oct 2019
Abstracts submission is now open!
08 Oct 2019
Making novel analytical methods acceptable for regulators and other decision makers requires their testing and validation prospectively...
Lugano, Switzerland
17 Oct
- 18 Oct
2019
Barcelona, Spain
21 Oct
- 22 Oct
2019
Valencia, Spain
25 Oct
- 26 Oct
2019
London, United Kingdom
07 Nov
- 09 Nov
2019
Vienna, Austria
14 Nov
- 17 Nov
2019
Singapore
20 Nov
- 21 Nov
2019
